ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 365,59
-0,21%
Dow Jones
42 867,32
0,76%
DAX
19 938,49
0,15%
Brent Oil
76,165
3,13%
Bitcoin
97 128,02
2,90%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. FibroBiologics Inc (FBLG)

  7. FibroBiologics Inc (FBLG) Actualités

FBLG

FibroBiologics (FBLG)

FibroBiologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FBLG
DateHeureSourceTitreSymboleSociété
31/12/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
30/12/202422h30GlobeNewswire Inc.FibroBiologics Closes Second $5 Million Tranche of $25 Million FinancingNASDAQ:FBLGFibroBiologics Inc
30/12/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
30/12/202420h12GlobeNewswire Inc.D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million FinancingNASDAQ:FBLGFibroBiologics Inc
30/12/202414h29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
23/12/202413h55GlobeNewswire Inc.FibroBiologics Announces $25 Million FinancingNASDAQ:FBLGFibroBiologics Inc
19/11/202415h15GlobeNewswire Inc.FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of SplenomegalyNASDAQ:FBLGFibroBiologics Inc
14/11/202415h15GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based TherapeuticsNASDAQ:FBLGFibroBiologics Inc
12/11/202422h20GlobeNewswire Inc.FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:FBLGFibroBiologics Inc
12/11/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
29/10/202414h15GlobeNewswire Inc.FibroBiologics Announces Updates for Novel Artificial Thymus Organoid TechnologyNASDAQ:FBLGFibroBiologics Inc
28/10/202414h31GlobeNewswire Inc.FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024NASDAQ:FBLGFibroBiologics Inc
18/10/202414h30GlobeNewswire Inc.FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic DiseasesNASDAQ:FBLGFibroBiologics Inc
16/10/202415h15GlobeNewswire Inc.FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent OfficeNASDAQ:FBLGFibroBiologics Inc
11/10/202415h31GlobeNewswire Inc.FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual SummitNASDAQ:FBLGFibroBiologics Inc
30/09/202415h31GlobeNewswire Inc.FibroBiologics to Present at 2024 Cell & Gene Meeting on the MesaNASDAQ:FBLGFibroBiologics Inc
19/09/202415h31GlobeNewswire Inc.FibroBiologics Engages Southern Star Research as CRO in AustraliaNASDAQ:FBLGFibroBiologics Inc
12/09/202415h31GlobeNewswire Inc.FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based TechnologyNASDAQ:FBLGFibroBiologics Inc
06/09/202415h31GlobeNewswire Inc.FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBLGFibroBiologics Inc
20/08/202415h31GlobeNewswire Inc.FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based TechnologyNASDAQ:FBLGFibroBiologics Inc
15/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBLGFibroBiologics Inc
13/08/202422h05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FBLGFibroBiologics Inc
13/08/202422h01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FBLGFibroBiologics Inc
08/08/202400h52GlobeNewswire Inc.FibroBiologics Files 2024 Second Quarter ReportNASDAQ:FBLGFibroBiologics Inc
15/07/202415h31GlobeNewswire Inc.FibroBiologics to Present at JonesTrading Healthcare Summit 2024NASDAQ:FBLGFibroBiologics Inc
25/06/202415h31GlobeNewswire Inc.FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyNASDAQ:FBLGFibroBiologics Inc
13/06/202415h31GlobeNewswire Inc.FibroBiologics Set to Join Russell 2000® IndexNASDAQ:FBLGFibroBiologics Inc
06/06/202416h58Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:FBLGFibroBiologics Inc
06/06/202415h31GlobeNewswire Inc.FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024NASDAQ:FBLGFibroBiologics Inc
04/06/202420h36Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FBLGFibroBiologics Inc
 Showing the most relevant articles for your search:NASDAQ:FBLG

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
FTSE
UKX
FTSE 100
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
EU
DG
Vinci
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
EU
AI
Air Liquide
NYSE
JPM
JP Morgan Chase
EU
ORA
Orange
NYSE
KO
Coca Cola
EU
BNP
BNP Paribas
EU
BN
Danone
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés